Kaveri Pohlman, PhD, is a Director and BTIG Biotechnology Analyst. She provides comprehensive coverage of the biotechnology sector with a focus on large and smidcap companies. Prior to BTIG, Dr. Pohlman was a Postdoctoral Research Associate at Weill Cornell Medical College, where her research work focused on understanding the pathogenesis of various subtypes of prostate cancer, defining the molecular biology underlying the disease progression, and identifying new therapeutic targets. She earned a PhD in molecular and cell biology from SUNY Downstate Medical Center, an MS in biotechnology from New York University’s Tandon School of Engineering, and an MBA from Birla Institute of Management Technology.